EUVIMEDEUVIMED entdecken
Metaanalyse

Safety and efficacy of carbamazepine in the treatment of trigeminal neuralgia: A metanalysis in biomedicine

M Guo, W Shen, M Zhou, Y Song, J Liu, W Xiong, Y Gao

Mathematical Biosciences and Engineering · 2024

DOI: 10.3934/mbe.2024235 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Mathematical Biosciences and Engineering, 2024. Verfasst von M Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Zhejiang University, Hangzhou, 310012, China. Hauptthemen laut MEDLINE: Carbamazepine, Trigeminal Neuralgia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trigeminal neuralgia is a debilitating condition characterized by severe facial pain. Carbamazepine has been widely used as a first-line treatment option for trigeminal neuralgia, but there is a need to evaluate its safety and efficacy based on existing evidence. This meta-analysis aims to systematically assess the available literature and provide a comprehensive evaluation of the safety and efficacy of carbamazepine in the treatment of trigeminal neuralgia. A thorough search of electronic databases yielded a total of 15 relevant studies that met the inclusion criteria. The pooled analysis of these studies revealed that carbamazepine demonstrated significant efficacy in reducing pain intensity and frequency in patients with trigeminal neuralgia. Moreover, the drug was generally well-tolerated, with the most common adverse events being mild and transient. Subgroup analyses based on different dosages and treatment durations further supported the overall findings. However, caution should be exercised in patients with certain comorbidities or specific populations, as some rare but severe adverse events were reported. In conclusion, this meta-analysis provides strong evidence supporting the safety and efficacy of carbamazepine as a valuable therapeutic option for the management of trigeminal neuralgia. These results can guide clinicians in making informed decisions regarding the use of carbamazepine and contribute to optimizing treatment strategies for patients with trigeminal neuralgia. Further research is warranted to explore long-term safety and efficacy outcomes, as well as to compare carbamazepine with alternative treatment modalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarbamazepineTrigeminal NeuralgiaHumansAnalgesics, Non-NarcoticTreatment Outcome

Stichwörter der Autor:innen

CarbamazepineTrigeminal neuralgiaefficacymeta-analysissafetytreatment

Substanzen

Analgesics, Non-NarcoticCarbamazepine

Autor:innen und Institutionen

  • Medical School, Zhejiang University, Hangzhou, 310012, China.
  • Liangzhu Laboratory, Zhejiang University, Hangzhou, 311113, China.
  • Medical Center (Yuhang), Zhejiang University, Hangzhou, 311121, China.
  • Department of Physiology Teaching, Nanchang University, Nanchang, 330006, China.

Zitieren

APA

Guo, M., Shen, W., Zhou, M., Song, Y., Liu, J., Xiong, W., & Gao, Y. (2024). Safety and efficacy of carbamazepine in the treatment of trigeminal neuralgia: A metanalysis in biomedicine. Mathematical Biosciences and Engineering. https://doi.org/10.3934/mbe.2024235

Vancouver

Guo M, Shen W, Zhou M, Song Y, Liu J, Xiong W, et al. Safety and efficacy of carbamazepine in the treatment of trigeminal neuralgia: A metanalysis in biomedicine. Mathematical Biosciences and Engineering. 2024. doi:10.3934/mbe.2024235

BibTeX
@article{Guo2024,
  author = {Guo, M and Shen, W and Zhou, M and Song, Y and Liu, J and Xiong, W and Gao, Y},
  title = {Safety and efficacy of carbamazepine in the treatment of trigeminal neuralgia: A metanalysis in biomedicine},
  journal = {Mathematical Biosciences and Engineering},
  year = {2024},
  doi = {10.3934/mbe.2024235}
}
Kostenlos starten →